Abstract
Colistin is a last-line antibiotic against Gram-negative pathogens. However, the emergence of colistin resistance has substantially reduced the clinical effectiveness of colistin. In this study, synergy between colistin and capric acid was examined against twenty-one Gram-negative bacterial isolates (four colistin-susceptible and seventeen colistin-resistant). Checkerboard assays showed a synergistic effect against all colistin-resistant strains [(FICI, fractional inhibitory concentration index) = 0.02–0.38] and two colistin-susceptible strains. Time–kill assays confirmed the combination was synergistic. We suggest that the combination of colistin and capric acid is a promising therapeutic strategy against Gram-negative colistin-resistant strains.
Funding Information
  • National Natural Science Foundation of China (31830099)
  • Science and Technology Program of Guangzhou (202201010300)
  • Project of Educational Commission of Guangdong Province of China (2021KQNCX006)
  • Science and Technology Program of Guangzhou, China (202201010300)
  • the Innovation Team Project of Guangdong University (2019KCXTD001)
  • the 111 Project (D20008)
  • National Natural Science Foundation of China (31830099)

This publication has 27 references indexed in Scilit: